ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

No reported Weighted Avg Shares (Diluted) figures are available to summarize.

Weighted Avg Shares (Diluted) history

Shares · from the income statement

No Weighted Avg Shares (Diluted) data reported for this period type.

Weighted Avg Shares (Diluted) vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors Peer median
Weighted Avg Shares (Diluted) for ADRX and competitors
Company Period LTM YoY 3-year CAGR
WVEWave Life Sciences Ltd.LTM Mar 2026178.01M +19.3%+28.8%
PRMEPrime Medicine, Inc.LTM Mar 2026153.89M +26.0%+15.2%
PRQRProQR Therapeutics N.V.LTM Mar 2026105.94M +21.0%+13.7%
MGTXMeiraGTx Holdings plcLTM Mar 202680.99M +13.7%+21.2%
STOKStoke Therapeutics, Inc.LTM Mar 202659.6M +4.3%+15.0%
BNTCBenitec Biopharma Inc.LTM Mar 202643.27M +112.6%+166.1%
SLNSilence Therapeutics plcLTM Mar 202631.49M —+63.9%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 202627.53M +1.8%+0.4%
RNAAtrium Therapeutics, Inc.FY202517.11M ——
ADRXADARx Pharmaceuticals, Inc.—— ——
Peer median (excluding ADRX) 59.6M+19.3%+18.2%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.